Insecticides (India) Limited has informed the Exchange about Investor Presentation
INSECTICID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Insecticides (India) Limited filed its Q1 FY2025-26 earnings presentation with the exchanges. Revenue grew 5% year-on-year to ₹691 crore, while EBITDA rose 17% to ₹85 crore with margins expanding 125 basis points to 12.2%. Profit after tax jumped 18% to ₹58 crore, supported by a 20% growth in premium products in the B2C segment. The company launched 7 new products in the quarter, including SPARCLE in collaboration with Corteva Agriscience, and shared that the share of premium products in B2C rose from 51% to 61% over FY23-FY25. ROCE improved to 17.8% and ROE to 13.1%, reflecting strong operational efficiency gains.
Double-digit profit growth alongside margin expansion and improving return ratios signals a healthy business momentum that should be viewed positively by shareholders. The premiumization strategy and new product pipeline provide a solid foundation for sustained earnings growth.